Table 4 Clinical characteristics and results of immunohistochemistry for ASCL1, DKK1 and TPH1
Tumour no | Gender | Age at diagnosis | WHO | Syndrome | ASCL1 | DKK1 | TPH1 |
|---|---|---|---|---|---|---|---|
1 | M | 53 | 2 | NF | High | Low | Heterogeneous |
2 | F | 47 | 1 | NF/MEN 1 | High | Low | Low |
3 | M | 50 | 2 | IN | High | Low | |
4 | F | 86 | 1 | IN | High | Low | |
5 | F | 40 | 1 | GA | High (p) | Low (p) | Heterogeneous |
6 | M | 44 | 2 | GL | High | Low | Heterogeneous |
7 | M | 51 | 2 | NF | Low | High | |
8 | F | 46 | 2 | NF | Low | High | |
9 | F | 34 | 2 | NF | Low | High | |
10 | M | 62 | 1 | NF/MEN 1 | Low | High (p) | Heterogeneous (p) |
11 | M | 53 | 2 | NF/MEN 1 | Low | High | |
12 | M | 48 | 2 | NF/MEN 1 | Low | N/D | Heterogeneous |
13 | M | 47 | 2 | IN | Low | High | Heterogeneous |
14 | M | 19 | 1 | IN/MEN 1 | Low | High | Heterogeneous |
15* | M | 53 | 2 | GL | Low | High | High |
16 | M | 72 | 2 | GA | Low | High | |
17 | M | 50 | 3 | NF | High | High | |
18 | F | 44 | 2 | NF | High | High | |
19 | F | 23 | 3 | NF | High | High | |
20 | M | 57 | 1 | NF/MEN 1 | High | High | High |
21 | F | 44 | 1 | NF | Low | Low | Heterogeneous |
22 | M | 22 | 1 | NF/MEN 1 | Low | Low | High/Heterogeneous |
23 | M | 64 | 1 | IN | Low (p) | Low |